Research Library

open-access-imgOpen AccessS quamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity
Author(s)
Turato Cristian,
Scarpa Melania,
Kotsafti Andromachi,
Cappon Andrea,
Quarta Santina,
Biasiolo Alessandra,
Cavallin Francesco,
Trevellin Elisabetta,
Guzzardo Vincenza,
Fassan Matteo,
ChiarionSileni Vanna,
Castoro Carlo,
Rugge Massimo,
Vettor Roberto,
Scarpa Marco,
Pontisso Patrizia
Publication year2019
Publication title
cancer science
Resource typeJournals
PublisherWiley-Blackwell
Squamous cell carcinoma antigen‐1 ( SCCA 1) overexpression is associated with poor prognosis and chemoresistance in several tumor types, however, the underlying mechanisms remain elusive. Here, we report SCCA 1 in relation to the immune and peritumoral adipose tissue microenvironment in early and advanced esophageal adenocarcinoma ( EAC ). In our series of patients with EAC, free SCCA 1 serum levels were associated with significantly worse overall survival, and SCCA 1‐IgM serum levels showed a trend to a worse overall survival. Serum SCCA 1 and intratumoral SCCA 1 were inversely correlated with immune activation markers. In agreement with these findings, SCCA 1 induced the expression of the immune checkpoint molecule programmed death ligand‐1 on monocytes and a direct correlation of these 2 molecules was observed in sequential tumor sections. Furthermore, SCCA 1 mRNA expression within the tumor was inversely correlated with stem cell marker expression both within the tumor and in the peritumoral adipose tissue. In vitro, in EAC cell lines treated with different chemotherapeutic drugs, cell viability was significantly modified by SCCA 1 presence, as cells overexpressing SCCA 1 were significantly more resistant to cell death. In conclusion, poor prognosis in EAC overexpressing SCCA 1 is due to reduced tumor chemosensitivity as well as intratumoral immunity impairment, likely induced by this molecule .
Subject(s)antigen , biology , cancer research , immune system , immunology
Language(s)English
SCImago Journal Rank2.035
H-Index141
eISSN1349-7006
pISSN1347-9032
DOI10.1111/cas.13986

Seeing content that should not be on Zendy? Contact us.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here